IOVS Blood
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weih, L. M.
Right arrow Articles by Keeffe, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weih, L. M.
Right arrow Articles by Keeffe, J.
(Investigative Ophthalmology and Visual Science. 2002;43:927-935.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Assessment of the Impact of Vision Impairment

LeAnn M. Weih, Jennifer B. Hassell and Jill Keeffe

From the Centre for Eye Research Australia, The University of Melbourne, Melbourne, Victoria, Australia.

PURPOSE. To describe the psychometric characteristics of the Impact of Vision Impairment (IVI) Profile and evaluate its validity and reliability over time and between different forms of administration.

METHODS. The IVI is a 32-item questionnaire developed to measure the impact of vision impairment on restriction of participation in daily activities in five domains of functioning. Each item is rated on a six-level scale from "no difficulty" to "can’t do because of vision." The IVI was administered by trained interviewers to 115 people with impaired vision (visual acuity less than 6/12 or visual field deficit) who attended the Royal Victorian Eye and Ear Hospital, a vision rehabilitation agency, or a self-help group for people with impaired vision. Data were also collected on demographic characteristics of participants, cause of vision impairment, and distance and near vision. General health status was assessed with the Short Form-12 (SF-12) of the Physical and Mental Health Summary Scales. A subset of participants completed the IVI twice, either 1 to 2 weeks apart or by different forms of administration (different interviewers or self).

RESULTS. Internal consistency of total and domain average IVI scores was high ({alpha} = 0.80–0.96) and sequential elimination of items did not affect consistency. Total and domain average IVI scores correlated moderately with both near and distance vision (r = 0.21–0.31) but did not correlate with physical or general health or comorbidity. Total and domain average IVI scores correlated most closely with global measures of restriction of participation (r = 0.44–0.82). Principal-components analysis confirmed that all IVI items contribute to one underlying theme and tended to confirm two of the five domains: emotional reaction to vision loss and mobility. The first three components explained 43%, 8%, and 6% of the variation in the data. Guttman split-half reliability coefficients between different forms of administration and over time ranged from 0.73 to 0.94 for domain and total IVI scores. Mean absolute difference for domain and total scores between administrations was less than 1 step for all domains and the total score.

CONCLUSIONS. This study provides support that the IVI has sufficient internal and construct validity to measure the effect of vision impairment on restriction of participation in daily activities. The IVI demonstrates acceptable reliability over a short period and yields consistent results between interviewers. The IVI can also be self-administered with assurance that the results will be comparable to those that would have been obtained by a trained interviewer. Therefore, the psychometric characteristics of the IVI support its use in assessment of the vision rehabilitation needs of people with impaired vision. Its stability over time indicates that it has potential to evaluate outcomes of intervention.




This article has been cited by other articles:


Home page
IOVSHome page
R. d. Toit, A. Palagyi, J. Ramke, G. Brian, and E. L. Lamoureux
Development and Validation of a Vision-Specific Quality-of-Life Questionnaire for Timor-Leste
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4284 - 4289.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. L. Lamoureux, J. F. Pallant, K. Pesudovs, G. Rees, J. B. Hassell, and J. E. Keeffe
The Effectiveness of Low-Vision Rehabilitation on Participation in Daily Living and Quality of Life
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1476 - 1482.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. L. Lamoureux, J. F. Pallant, K. Pesudovs, G. Rees, J. B. Hassell, and J. E. Keeffe
The Impact of Vision Impairment Questionnaire: An Assessment of Its Domain Structure Using Confirmatory Factor Analysis and Rasch Analysis
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1001 - 1006.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. L. Lamoureux, J. F. Pallant, K. Pesudovs, J. B. Hassell, and J. E. Keeffe
The Impact of Vision Impairment Questionnaire: An Evaluation of Its Measurement Properties using Rasch Analysis
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4732 - 4741.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
J B Hassell, E L Lamoureux, and J E Keeffe
Impact of age related macular degeneration on quality of life
Br. J. Ophthalmol., May 1, 2006; 90(5): 593 - 596.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
E. A. Bradley, D. Bradley, and G. B. Bartley
Evaluating Health-Related Quality of Life in Ophthalmic Disease: Practical Considerations
Arch Ophthalmol, January 1, 2006; 124(1): 121 - 122.
[Full Text] [PDF]


Home page
IOVSHome page
R. Misajon, G. Hawthorne, J. Richardson, J. Barton, S. Peacock, A. Iezzi, and J. Keeffe
Vision and Quality of Life: The Development of a Utility Measure
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4007 - 4015.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
H T V Vu, J E Keeffe, C A McCarty, and H R Taylor
Impact of unilateral and bilateral vision loss on quality of life
Br. J. Ophthalmol., March 1, 2005; 89(3): 360 - 363.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. R. Taylor, H. T. V. Vu, C. A. McCarty, and J. E. Keeffe
The Need for Routine Eye Examinations
Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2539 - 2542.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
E. L. Lamoureux, J. B. Hassell, and J. E. Keeffe
The Impact of Diabetic Retinopathy on Participation in Daily Living
Arch Ophthalmol, January 1, 2004; 122(1): 84 - 88.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology